In this study, we report the results of an educational program for pathologists from all over Italy (Rome, May 2023) aimed at investigating the PD-L1 evaluation with CPS scoring in a series of selected cases of HNSCC from different Italian Pathology centers, using both LDTs and the CDx approved by FDA. The gene discussed is CD274; the disease is head and neck squamous cell carcinoma.